Express Pharma

APRIL 29, 2024

A trained scientist turned entrepreneur, Swaroop leverages a decade of experience in the pharmaceutical sector, followed by 2 decades in the Natural Products sector. In this interview, Swaroop lists the criteria he would look for in potential investees, stresing on products and ideas based on the 3 Ss – safety, science, and sustainability.

92

92

Pharmaceutical Business Review

MAY 14, 2024

The production and laboratory space featured at the facility is designed to enable PharmaLogic to scale up its existing production capabilities. The latest development comes after the company unveiled its new radiopharmaceutical production and research facility in Cincinnati, Ohio in the US, in April this year.

Compounding 59

Compounding 59

European Pharmaceutical Review

FEBRUARY 3, 2023

Switzerland-based contract development and manufacturing organisation (CDMO) CARBOGEN AMCIS has opened a new facility in France, dedicated to the custom development and production of sterile injectable drug products. The lines offer a flexible and versatile set up, which is unique within Europe.

Dosage 91

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 91

European Pharmaceutical Review

APRIL 11, 2024

This is because they can selectively manipulate processes in the body such as “gene expression, splicing, and protein production”, the companies explained. “Moreover, our involvement from the very early stages of the project allows us to support and facilitate future scale-up efficiently.”

52

52

Express Pharma

FEBRUARY 2, 2024

Venture funding from a foreign country may force them to set up in that country, which some startups might do to attract venture funding. However, a critical gap exists in access to pilot-scale or scale-up facilities. This inability to scale up poses a significant pain point.

Vaccines 104

Vaccines 104

Express Pharma

FEBRUARY 12, 2024

Fredun Pharmaceuticals announced significant milestones in its business expansion and product development initiatives. These orders demonstrate the company’s growing presence in the international markets and hold substantial potential to scale up over the years.

64

64

PharmaTech

JUNE 18, 2023

How to achieve robust and consistent high-quality productivity for successful commercial manufacturing is dependent on clearly defining your criteria for successful scale-up.

52

52

Pharmaceutical Technology

AUGUST 2, 2022

Samsung Biologics and GreenLight Biosciences have completed the initial commercial-scale engineering run for their messenger ribonucleic acid (mRNA) Covid-19 vaccine under their manufacturing collaboration. Furthermore, the mRNA synthesis reaction of GreenLight had a titer of 12g/L at a commercial scale and yielded 650g mRNA.

Vaccines 104

Vaccines 104

European Pharmaceutical Review

SEPTEMBER 21, 2023

To establish it, the Novo Nordisk Foundation is committing up to £127 million. A few hospitals in Denmark already have small-scale facilities for manufacturing products for these innovative treatments. A few hospitals in Denmark already have small-scale facilities for manufacturing products for these innovative treatments.

Hospitals 107

Hospitals 107

European Pharmaceutical Review

NOVEMBER 9, 2023

When it comes to biologics, scaling up production to ensure global supply is a remarkable process that embodies Industry 4.0 and the very latest in advanced manufacturing technologies. We also explore opportunities for outsourcing of regulatory activities, the challenges of paediatric drug formulation and much more.

Biosimilars 80

Biosimilars Drug Development 80

Express Pharma

JANUARY 23, 2024

The addition of SII to the CEPI manufacturing network will be a significant boost to vaccine production efforts in Global South regions and will mean the world is better prepared to achieve the 100 Days Mission to develop new vaccines against known or novel infectious diseases within three months of a pandemic threat being recognised.

Vaccines 98

Vaccines 98

STAT

JANUARY 17, 2023

We hope your day is productive and meaningful. … After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back efforts to produce the shots as it faces slumping demand , The Wall Street Journal reports. government, has not lived up to expectations.

Vaccines 180

Vaccines Drug Pricing 180

European Pharmaceutical Review

NOVEMBER 24, 2023

billion (16 billion Danish kroner) to expand its production site in Chartres, France, supporting manufacture of its products for serious chronic diseases. Aseptic production and finished production processes will be added to the site, as well as an extension of the current Quality Control Laboratory.

Pharmaceutical Manufacturing 95

Pharmaceutical Manufacturing Packaging 95

European Pharmaceutical Review

DECEMBER 9, 2022

Catalent, a contract manufacturing organisation (CMO), has opened one of the largest commercial-scale cell therapy manufacturing facilities in the world, at its European Center of Excellence for Cell Therapies in Gosselies, Belgium. Manufacturing facilities at the Gosselies campus . Catalent cell therapy manufacturing.

Vaccines 78

Vaccines 78

Express Pharma

MAY 6, 2024

Attendees discussed innovative models for production and packaging, sustainable eco-packaging solutions and strategies for optimising the pharmaceutical supply chain. They examined packaging compliance, promoting sustainability and scaling up production with efficient project management and eco-friendly solutions.

Packaging 94

Packaging Pharmaceutical Manufacturing Labelling Pharmaceutical Companies 94

European Pharmaceutical Review

JUNE 27, 2023

The companies will partner in the process development and manufacturing scale-up at a new, large-scale facility in Portsmouth, New Hampshire, US. Operated by Lonza, the 130,000 square foot facility is anticipated to create up to 300 new jobs at peak capacity.

Diabetes 93

Diabetes Immunity Immunization 93

European Pharmaceutical Review

AUGUST 25, 2022

DURING THE development of new types of active pharmaceutical ingredients (APIs) or medicinal products, scale-up at a pilot plant is an important proof of concept. Water may be found in raw materials, where it can impact blending, granulation and synthetic reactions, as well as intermediate and final products.

91

91

Pharmaceutical Business Review

JANUARY 18, 2024

Located in Mississauga, Canada, the 3,300ft 2 facility is designed for the development and scaling of monoclonal antibodies and other mammalian-based therapeutic proteins. Eurofins CDMO Alphora is engaged in providing active pharmaceutical ingredients (API’s) / drug substance and drug product development for small molecules and biologics.

Packaging 59

Packaging 59

European Pharmaceutical Review

MAY 2, 2024

There are a lot of conjugated products in the clinical pipeline and novel conjugation partners and chemistries are being tried. Automated microbioreactors have been in place for many years, and these platforms are being used as validated scale-down models for large-scale bioreactors. How can these be overcome?

Biosimilars 97

Biosimilars Drug Development 97

Express Pharma

MAY 15, 2024

Packaging and labelling, being an integral part of the products, are also transforming by adopting such contemporary technologies to remain at par with the industry standards across the globe. It can also help to enhance productivity, minimise process cycle time, improve accuracy and maintain consistency.

Packaging 83

Packaging Labelling 83

Express Pharma

JANUARY 31, 2024

The second Master Class in this series is by Mr Masihuddin Jaigirdar on Product & Process related regulatory issues in the submitted ANDAs. The second session covered Drug Product & Manufacturing and this video, the third session, will focus on Common Deficiencies during Scale-up.

52

52

Express Pharma

JANUARY 31, 2024

The second Master Class in this series is by Mr Masihuddin Jaigirdar on Product & Process related regulatory issues in the submitted ANDAs. This video, the second session, will cover Drug Product & Manufacturing and the third session to follow, will focus on Common Deficiencies during Scale-up.

52

52

Express Pharma

JANUARY 31, 2024

The second Master Class in this series is by Mr Masihuddin Jaigirdar on Product & Process related regulatory issues in the submitted ANDAs. The second session will cover Drug Product & Manufacturing and the third session will focus on Common Deficiencies during Scale-up.

52

52

Express Pharma

MAY 15, 2023

Applications of these end products range from food and animal feeds to active pharma ingredients (APIs) that are used in medicinal products. Typically, our products support the separation of biomolecules from complex biomass mixtures and play a key role in their further purification or stabilisation.

86

86

Express Pharma

JULY 29, 2023

In this video: Sourabh Sobti, Business Development Lead, CEPI Topic: Investments in vaccine delivery Key Highlights: 1) Create vaccine libraries against representative pathogens from virus families with greatest pandemic potential 2) Establish global clinical trials and laboratory networks with pre-established processes and protocols to enable rapid (..)

Vaccines 52

Vaccines 52

PharmaTech

NOVEMBER 14, 2023

Download the article to learn how lipid-based formulation allows for the timely completion of early and late-phase development activities, and provides relatively straightforward scale-up dosage form manufacturing to meet the commercial volume demand requirements for newly launched products.

Dosage 40

Dosage 40

European Pharmaceutical Review

OCTOBER 24, 2022

Three trade bodies representing vaccine creators and manufacturers are endorsing The Berlin Declaration framework , a proposal that outlines how the industry would reserve an allocation of real-time vaccine production for swift distribution to priority populations in lower-income countries in future pandemics.

Vaccines 63

Vaccines Pharmaceutical Manufacturing 63

PharmaTech

JUNE 18, 2023

As processes increase in scale, the greater raw material volumes and stricter quality requirements can make it challenging to deliver an effective and economically feasible product.

40

40

European Pharmaceutical Review

MARCH 7, 2024

Last month, construction began on Europe’s first industrial-scale facility dedicated to the production of lead-212 based radioligand therapies. A report from Technavio suggests that due to trends in the nuclear medicine market such as isotope production, the radiopharmaceuticals market will grow by $4.61

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Immunity Immunization 52

PharmaTech

APRIL 25, 2023

This case study summarizes the outcomes of several media optimization projects and how the results helped manufacturers to achieve their desired scale-up goals, including enhancing productivity, maintaining product quality, and potentially improving return on investment (ROI).

40

40

PharmaTech

OCTOBER 12, 2023

In order to produce granules with the desired properties, scale-up is crucial, in addition to looking at the process parameters. After all, the path of a drug from the laboratory to production holds many a surprise. Do you face challenges when it comes to the particle quality in your granulation process?

52

52

Pharma Mirror

MAY 31, 2023

In the face of increasing global health challenges, the development and production of vaccines have become paramount. One critical aspect is the ability to scale up manufacturing processes to meet the growing demand for viral vector-based vaccines.

Vaccines 52

Vaccines Pharmaceutical Manufacturing 52

Pharmaceutical Technology

SEPTEMBER 7, 2022

Bharat Biotech carried out the product development linked to preclinical safety assessment, large-scale production scale-up, as well as the development of formulation and delivery device, including trials in humans. iNCOVACC has been designed for efficient distribution and easy administration.”.

Vaccines 105

Vaccines 105

Express Pharma

MARCH 4, 2024

The biocluster will serve as an accelerator for startups, academia, MSMEs, and industries, providing state-of-the-art infrastructure and expertise for faster development of biopharma products. The biocluster also aims to set up a Good Manufacturing Practice (GMP) facility, enabling drug development at an affordable cost.

Drug Development 104

Drug Development Vaccines 104

pharmaphorum

APRIL 6, 2022

The growth of a start-up after obtaining Series A funding is a transformational phase when scaling up the company becomes critical. The CEO can experience pressure to deliver on the revenue growth goals, whilst still developing their product, growing the team, and implementing core processes for the company.

52

52

Pharma Leaders

APRIL 9, 2023

Marmara Research Center (MAM) and The Scientific and Technological Research Council of Türkiye (TÜBITAK) have commenced Medical Biotechnology Research Center (MEDIBIYO) for the production of drugs and vaccines on a pilot scale, reported Daily Sabah. After to that, an area was set up to back small-scale production.

Vaccines 52

Vaccines Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

NOVEMBER 16, 2022

For young biotechs, scaling up production brings green-field challenges, while for more established pharma a shift may be required to ensure that facilities are optimised for new ways of working. That is because of the relative expense of emerging therapies and the pressure on pricing for continuing product lines.

Documentation 111

Documentation Vaccines Drug Development 111